Skip to content

Drawing up a guideline for ethanol lock therapy to treat catheter-related blood stream infection in pediatric patients.

Drawing up a guideline for ethanol lock therapy to treat catheter-related blood stream infection in pediatric patients. - Drawing up a guideline for ethanol lock therapy to treat catheter-related blood stream infection in pediatric patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030116
Enrollment
50
Registered
2017-12-01
Start date
2015-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

catheter-related blood stream infection

Interventions

1) After flush the contents of the catheter with physiological saline, slowly inject 0.1 to 0.7 mL of 70% ethanol into the catheter and lock it for 2 to 4 hours. 2) After locking, firstly aspirate di

Sponsors

The Japanese Society for Metabolism Research in Pediatric Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Long-term indwelling silicone CVC (Cook, Broviac or Hickman catheter) is placed. 2) Diagnosed as CRBSI. 3) There is consent from the family. 4) Obtained consent from the clinical trial judging committee.

Exclusion criteria

Exclusion criteria: 1) Patients with ethanol allergy 2) Pregnant women, breast milk supplier 3) Patients with hypercoagulability or easy coagulability 4) Patients who can not reverse blood from CVC 5) Patients who can not use ethanol socially, religiously or culturally 6) Patients whose CVC has been detained in another hospital, fewer information including catheter materials, and this method is judged to be maladaptive 7) Patients who have placed PICC or port type CVC 8) Patients who have placed double-lumen CVC and can not lock both lumens at the same time 9) Patients who doctor concluded that it is inappropriate to participate in this study

Design outcomes

Primary

MeasureTime frame
1) Short term assessment of efficacy The definition of successful CVC-ELT required negative blood culture from the lumen of the CVC at day 5 with improvement of blood biochemical examination, disappearance of clinical symptoms such as fever, and no CRBSI relapse within 4 weeks. 2) Evaluation on long-term preservation of CVC Evaluate whether catheter preservation was possible for 4 weeks or more.

Secondary

MeasureTime frame
Evaluation of safety a) Presence or absence of skin flushing, drunkenness, nausea etc. during the treatment period b) Presence or absence of liver and kidney dysfunction (BUN, Cr, AST, ALT on day 2.5)

Countries

Japan

Contacts

Public ContactSachiko Miyagawa

Showa University Hospital Division of Pediatric Surgery, Department of Surgery

jsmrps@med.showa-u.ac.jp03-3784-8000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026